Ми поєднуємо молекулярну мікробіологію, біоінформатику та штучний інтелект, щоб створювати продукти, які допомагають людям жити довше, здоровіше і в гармонії з довкіллям.
Наша місія — зробити науку доступною, а технології — персональними.
Ediens — це українська біотехнологічна компанія, яка формує нову епоху персоналізованої медицини та науки про мікробіом.
Ready to invest in the future of biotechnology?
Email: invest@ediens.me
Phone: +38 044 123 4567
Address: Kyiv, Ukraine
Ediens financial potential
Key indicators:
+75%
Expected revenue growth in 2024
40-60%
Product Marginality
???
Current investors and funding rounds
How we earn and expand
Ediens operates under the Science-to-Business model, transforming cutting-edge scientific developments into profitable products and solutions
Sales of innovative probiotics
(B2C and B2B segments)
Personalized dietary supplements
Analytics + recommendations
Microbiome diagnostic services
Subscription
Ecological solutions for water and soil purification
Technology licensing and partner programs
Why is Ediens a profitable investment?
A powerful biotechnology market
The global microbiome market is estimated at $56 billion and is growing by 13% annually. We have unique technologies and solutions that meet current trends.
Venture financing
For large investors
Co-investment in projects
For private investors
Strategic partnership
For business
Why is Ediens a profitable investment?
Scientific base and partnerships
Ediens collaborates with leading universities, research centers, and medical institutions. Our developments are based on cutting-edge research in the field of microbiome and biotechnology.
Why is Ediens a profitable investment?
Innovative products with high margins
We create next-generation probiotics, personalized nutraceuticals, and environmental solutions that have high commercial appeal.
